Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

682 evidence items · page 7 / 28

0.9 %The range of foetal haemoglobin (HbF) levels in sickle cell anaemia patients in Nigeria was 0.9% to 16.7%.

Nigeriadrépanocytosepublished 1990European journal of haematologyeurope_pmcdocument of 5 observations

60 %Among 3622 enrolled sickle cell disease patients in Nigeria, 60% had experienced bone pain crisis.

Nigeriabone pain crisis · drépanocytosepublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

14.9 %Chronic hepatitis B infection was the most prevalent complication, seen in 14.9% of the children.

Nigeriadrépanocytose · hépatite Bpublished 2021West African journal of medicinePubMeddocument of 10 observations

57.6 %Among 85 children with mild sickle cell disease, 49 (57.6%) had ocular abnormalities.

Nigeriadrépanocytosepublished 2021European journal of ophthalmologyPubMeddocument of 3 observations

99 %For HbAC phenotype, isoelectric focusing showed a specificity of 99%.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations

50.3 %In 50.3% of encounters, patients with sickle cell disease managed by short-term emergency department observation care were successfully managed without requiring further care.

Nigeriadrépanocytoseobserved July 2017 to June 2019published 2020Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 6 observations

25.7 %Automated red cell exchange for sickle cell disease accounted for 25.7% of procedures at one center in Nigeria.

NigeriadrépanocytosePubMeddocument of 6 observations

18.7 %Overall prevalence of sickle cell trait (AS) was 18.7%.

Nigeriadrépanocytose · trait drépanocytairepublished 2021BMC pregnancy and childbirtheurope_pmcdocument of 4 observationsDOI 10.1186/s12884-021-03974-4

77.7 %In a cohort of 193 children with sickle cell disease in Nigeria, peak systolic blood velocity (PSV) was normal in 150 (77.7%), high in 7 (3.6%), and conditional in 36 (18.7%).

Nigeriadrépanocytosepublished 2023Archives of disease in childhoodPubMeddocument of 5 observations

2.64 odds_ratioIn multivariate analysis, tingling was associated with painful crisis with an odds ratio of 2.64.

NigeriadrépanocytosePubMeddocument of 10 observations

20.8 %The prevalence of myocardial ischemia measuring electrocardiography alone in children with sickle cell anemia in steady state was 20.8%.

Nigeriadrépanocytose · myocardial ischemiaobserved 2019published 2024Journal of tropical pediatricsPubMeddocument of 6 observations

2.4 %7 (2.4%) of the caregivers disagreed that Newborn Screening for Sickle Cell Disease helps in the early detection and management of Sickle Cell Disease.

Nigeriadrépanocytosepublished 2024Frontiers in public healtheurope_pmcdocument of 8 observations

4 foldPatients with the BEN/SEN haplotype showed a four-fold lower frequency of painful episodes compared to other haplotypes.

Nigeriadrépanocytosepublished 2021The Journal of international medical researchPubMeddocument of 5 observations

27.92 yearsThe mean age of the SCD participants was 27.92 years.

Nigeriadrépanocytosepublished 2021ImmunohematologyPubMeddocument of 7 observations

39.6 %Fifty-three (39.6%) of the children had hepatobiliary abnormalities.

Nigeriadrépanocytosepublished 2021West African journal of medicinePubMeddocument of 10 observations

34 %Among 108 children who completed the feasibility trial for managing severe acute malnutrition in older children with sickle cell anemia in Nigeria, 34% (n = 37) had very low food security.

Nigeriadrépanocytose · malnutritionpublished 2025Pediatric blood & cancerPubMeddocument of 4 observations

19.2 %Among 26 alloimmunized sickle cell disease participants, Kell alloantibodies were observed in 19.2%.

Nigeriadrépanocytosepublished 2025Transfusion and apheresis science : official journal of the World Apheresis Association : europe_pmcdocument of 9 observations

Higher malondialdehyde (MDA) level was associated with very severe vaso-occlusive crisis in sickle cell anaemia individuals.

Nigeriadrépanocytose · vaso-occlusive crisispublished 2021African health sciencesPubMeddocument of 7 observations

-0.06 kappaMeasures of agreement between ECG and cTnT in detecting myocardial injury were poor during the follow-up steady state (κ -0.06, p = 0.63).

Nigeriadrépanocytosepublished 2020Paediatrics and international child healtheurope_pmcdocument of 8 observations

4.15 cmLeft kidney breadth was significantly greater in sickle cell anemia patients (4.15 ± 0.92 cm vs. 3.79 ± 0.48 cm).

Nigeriadrépanocytosepublished 2023Nigerian journal of clinical practicePubMeddocument of 9 observations

68 patientsSixty-eight had leg ulcers.

Nigeriadrépanocytosepublished 2021Hematology (Amsterdam, Netherlands)PubMeddocument of 16 observations

7.5 %Socio-demographic factors explained 7.5% of the variance in utility score in people with sickle cell disease.

Nigeriadrépanocytosepublished 2019PloS onePubMeddocument of 5 observations

No severe adverse effects were observed with the simplified hydroxyurea dosing regimen in paediatric sickle cell anaemia patients in South East Nigeria.

Nigeriadrépanocytoseobserved 2022–2024published 2025BMC pediatricsPubMeddocument of 3 observations

39 %Among 138 newly diagnosed sickle cell disease patients, 39% (0.63% SCD prevalence) were adults and 61% (1% SCD prevalence) were in the pediatric age-group.

Nigeriadrépanocytoseobserved 2013 to 2014published 2022The Pan African medical journalPubMeddocument of 9 observations

Serum bilirubin levels differed significantly among young Nigerian SCA patients when differentiated by UGT1A1 (TA)n genotypes (p < 0.05).

Nigeriadrépanocytosepublished 2019BMC medical geneticsPubMeddocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.